Expands access to Fresenius Medical Care's globally established portfolio of advanced kidney replacement therapies in the U.S ...

Revenue of $716.0 million in the third quarter of 2026 increased 8.5% from revenue of $659.9 million for the comparable prior ...

Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that it is scheduled to report third quarter results on November 4, ...

Jefferies, Leerink Partners and TD Cowen are acting as joint book-running managers.

BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its third quarter 2026 financial ...

Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and ...

The $100,000 H-1B visa fee has significantly affected who biopharma companies hire, according to two experts. It’s not the ...

Securing financing that allowed an exit from academia, leaving ecology and evolutionary biology for biomedical engineering ...

Company to host conference call and webcast on Wednesday, November 4, 2026, at 4:30 p.m. Eastern Time SAN DIEGO--(BUSINESS ...

At the European Society for Medical Oncology meeting this weekend, Merck will showcase three late-stage trials of its ...

The fireside chat, "Building a Program for Patient Access in Atopic Dermatitis,” will focus on the company’s strategy for ...

Discovery may help develop treatments for Andes virus and other hantaviruses. BRONX, N.Y., Oct. /PRNewswire/ -- Earlier this ...